Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sanofi (SNY) Non Operating Investment Income (2016)

Sanofi's Non Operating Investment Income history spans 6 years, with the latest figure at -$135.0 million for Q4 2016.

  • On a quarterly basis, Non Operating Investment Income rose 67.68% to -$135.0 million in Q4 2016 year-over-year; TTM through Dec 2016 was -$799.5 million, a 4.14% decrease, with the full-year FY2016 number at -$135.0 million, up 68.85% from a year prior.
  • Non Operating Investment Income hit -$135.0 million in Q4 2016 for Sanofi, down from -$130.2 million in the prior quarter.
  • Over the last five years, Non Operating Investment Income for SNY hit a ceiling of -$104.1 million in Q1 2014 and a floor of -$417.6 million in Q4 2015.
  • Historically, Non Operating Investment Income has averaged -$163.6 million across 4 years, with a median of -$137.6 million in 2013.
  • Biggest five-year swings in Non Operating Investment Income: plummeted 142.13% in 2015 and later soared 67.68% in 2016.
  • Tracing SNY's Non Operating Investment Income over 4 years: stood at -$140.2 million in 2013, then fell by 23.03% to -$172.5 million in 2014, then tumbled by 142.13% to -$417.6 million in 2015, then surged by 67.68% to -$135.0 million in 2016.
  • Business Quant data shows Non Operating Investment Income for SNY at -$135.0 million in Q4 2016, -$130.2 million in Q1 2016, and -$417.6 million in Q4 2015.